Kristin G. Mohn
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adults.
Journal: Vaccine: X
Published: July 19, 2024
Impact of Pre-Existing Immunity and Age on Antibody Responses to Live Attenuated Influenza Vaccine.
Journal: Vaccines
Published: June 05, 2024
SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients.
Journal: Frontiers in immunology
Published: September 01, 2023
SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity.
Journal: The Journal of infection
Published: May 14, 2023
Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment.
Journal: Viruses
Published: July 07, 2022
Lower antibiotic prescription rates in hospitalized COVID-19 patients than influenza patients, a prospective study.
Journal: Infectious diseases (London, England)
Published: September 16, 2021
Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients.
Journal: PloS one
Published: July 05, 2021
Humoral and cellular immune responses in critically ill influenza A/H1N1-infected patients.
Journal: Scandinavian journal of immunology
Published: November 04, 2020
Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
Journal: The Journal of infectious diseases
Published: July 12, 2019
Live-Attenuated Influenza Vaccine Induces Tonsillar Follicular T Helper Cell Responses That Correlate With Antibody Induction.
Journal: The Journal of infectious diseases
Published: January 23, 2019
Last Updated: 09/26/2026